Stay updated with breaking news from Global Impression. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Final results were announced from a phase 3 trial evaluating SP-102 (injectable dexamethasone sodium phosphate viscous gel) for the treatment of lumbosacral radicular pain, or sciatica.
Published reports of clinical trials of psychiatric drugs typically include a graphic showing the efficacy of the study drug in reducing symptoms of the di
Improvement with 50-mg zuranolone seen by day 3
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Addex Therapeutics Initiates Pivotal Phase 2b/3 Study with Dipraglurant for Dyskinesia ... Addex TherapeuticsJune 29, 2021 GMT Geneva, Switzerland, June 29, 2021 - Addex Therapeutics Ltd (SIX: ADXN, Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today that screening of patients has started for its pivotal Phase 2b/3 study with dipraglurant for dyskinesia associated with Parkinson’s disease (PD-LID). Dyskines...
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Sio Gene Therapies Announces Positive Six-Month Follow-Up Data from Low-Dose Cohort of Phase ... Sio Gene TherapiesDecember 15, 2020 GMT - Generally well-tolerated with a favorable safety profile in five patients - Serum beta-galactosidase enzyme activity increased in all patients at all timepoints between Day 7 and Month 6, representing an approximate doubling in enzyme activity after gene transfer - At Month 6, enzyme activity restored to 23-57% (mean: 38%) of normal reference levels - ...